glp-1 egfr cut off Updated algorithm to choose the optimum antidiabetic therapy between GLP-1 Receptor Agonists and Diabetic

She answered some FAQs about the drugs, including whos eligible

They only stimulate insulin release when blood sugar is elevated

Its unsuitable for those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2

Many people struggle with weight loss, even when they eat healthily and stay active

Gastroenterology 2024;167(2):402404.e3

They concluded that incretin-based medications did not correlate with an increased risk of acute pancreatitis or pancreatic cancer compared to other oral anti-diabetic agents, which remained consistent across drug classification and duration of use [29,55]